Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.

Louie, T; Miller, M; Donskey, C; Mullane, K; Goldstein, E J C

Louie, T; Miller, M; Donskey, C; Mullane, K; Goldstein, E J C.

Affiliation

Louie T; University of Calgary, Calgary, Alberta, Canada. louie@ucalgary.ca

Antimicrob Agents Chemother ; 53(1): 223-8, 2009 Jan.

Article in En | MEDLINE | ID: mdl-18955525

Subject(s)

Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/pharmacokinetics; Clostridioides difficile/drug effects; Clostridium Infections/drug therapy; Glycosides/adverse effects; Glycosides/pharmacokinetics; Adult; Aged; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycosides/pharmacology; Glycosides/therapeutic use; Humans; Male; Middle Aged; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections / Glycosides / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2009 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google